Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,510 JPY | +1.68% | +2.23% | -13.17% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
Sales 2024 * | 46.15B 295M | Sales 2025 * | 50.77B 325M | Capitalization | 36.71B 235M |
---|---|---|---|---|---|
Net income 2024 * | 5.83B 37.29M | Net income 2025 * | 3.86B 24.66M | EV / Sales 2024 * | 1.36 x |
Net Debt 2024 * | 25.86B 165M | Net Debt 2025 * | 24.69B 158M | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
6.3
x | P/E ratio 2025 * |
9.52
x | Employees | 1,621 |
Yield 2024 * |
2.81% | Yield 2025 * |
2.99% | Free-Float | 49.53% |
1 day | +1.68% | ||
1 week | +2.23% | ||
Current month | +1.68% | ||
1 month | -5.68% | ||
3 months | -11.33% | ||
6 months | -1.69% | ||
Current year | -13.17% |
Managers | Title | Age | Since |
---|---|---|---|
Takayuki Iwai
PSD | President | 60 | 06-11-30 |
Hirofumi Imai
CHM | Chairman | 60 | 87-03-31 |
Hiroshi Uji
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
BRD | Director/Board Member | 54 | 18-10-31 |
Keiji Hirai
BRD | Director/Board Member | 74 | 16-11-30 |
Director/Board Member | 71 | 17-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 19 M€ | +11.04% | ||
0.00% | 45 M€ | -.--% | - | |
0.00% | 17 M€ | +14.54% | - | |
0.00% | 140,441 M€ | +19.56% | ||
0.00% | 63,295 M€ | +19.64% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 1,510 | +1.68% | 51,600 |
24-05-31 | 1,485 | +1.85% | 88,100 |
24-05-30 | 1,458 | +0.07% | 57,000 |
24-05-29 | 1,457 | -1.15% | 42,100 |
24-05-28 | 1,474 | -1.73% | 93,900 |
Delayed Quote Japan Exchange, June 03, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.17% | 230M | |
+42.63% | 739B | |
+32.34% | 598B | |
-5.82% | 353B | |
+17.50% | 318B | |
+3.77% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.58% | 164B |
- Stock Market
- Equities
- 4554 Stock